Companion Medical, a company based in San Diego, landed the European CE Mark of approval for its InPen insulin management system. The InPen, which is already available in the United States, works like a common insulin pen, but also with the ability to send its usage data to paired smartphone. The data is used to help calculate future insulin dose recommendations, to keep one’s physician up-to-date on the patient’s compliance, and to help adjust therapy as necessary.
While the Insights app, that works with the InPen, recommends the dosage amounts, the user still has to manually input that setting on the pen before injections. This is an important safety feature, as it allows the patient to use the InPen even if the paired-up smartphone is not available.
The app creates a report that shows aggregated glucose, insulin, and meal data, on a day-by-day basis. The combination of all these relevant factors in one place can help to more easily identify any causes for abnormal glucose levels that can vary widely and often seemingly without reason.
Here’s a promo video for the InPen:
Flashback: InPen: A Smart Insulin Pen That Calculates Dosage, Tracks Injections…
Product page: InPen…
Via: Companion Medical…